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Context. Increasing numbers of people will die from chronic disease. Families contribute significantly to end-of-life care,
but their role may not be recognized.
Objectives. To 1) establish the proportion of older cohabitees identified in primary care as ‘‘carers’’; 2) describe
demographic and lifestyle characteristics of cohabitees of people terminally ill with cancer, dementia, and chronic obstructive
pulmonary disease (COPD); 3) describe their health a year before and after bereavement; and 4) compare health outcomes
between cohabitees of people dying with cancer, COPD, or dementia.
Methods. Retrospective cohort study using a U.K. primary care database (The Health Improvement Network) of 13,693
bereaved cohabitees (a proxy marker for being a carer), aged 60 years or older of people dying from cancer, COPD, or
dementia. Characteristics were described one year before and after bereavement. We compared cancer, COPD, and dementia
cohabitee outcomes using incidence rate ratios one year before and after bereavement and calculated mortality risk after
bereavement.
Results. A total of 6.9% of cohabitees were recorded as carers. Health outcomes differed little between the three groups of
cohabitees in the year before or after bereavement. The proportion of cohabitees with six or more consultations increased the
year after bereavement (cancer cohabitees 16.0% to 18.8%, COPD cohabitees 17.8% to 20.4%, and dementia cohabitees
15.5% to 17.5%). At postbereavement (follow-up median 3 years, interquartile range 1.3e5.4), we found no mortality
differences between the three groups.
Conclusion. Recording of carers of terminally ill people was suboptimal. Cause of bereavement produced few
differential effects on health outcomes or mortality. J Pain Symptom Manage 2016;51:839e848.  2016 The Authors. Published
by Elsevier Inc. on behalf of American Academy of Hospice and Palliative Medicine. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Introduction A variety of terms encompass this role, for example,Informal and family carers contribute greatly to
health and social care. There are approximately 65.7
million carers in the U.S. and 6.5 million in the U.K.
1,2 In the U.K., since 2010, carers’ financial contribu-
tion outstripped the total cost of the National Health
Service (£98.8 billion per annum).1Address correspondence to: Elizabeth L. Sampson, MD, Division
of Psychiatry, Marie Curie Palliative Care Research Depart-
ment, University College London, London W1T 7NF,
United Kingdom. E-mail: e.sampson@ucl.ac.uk
 2016 The Authors. Published by Elsevier Inc. on behalf of American
Academy of Hospice and Palliative Medicine. This is an open access
article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).‘‘carer,’’ ‘‘informal carer,’’ or ‘‘family carer.’’ The U.K.
National Institute for Health and Clinical Excellence
states ‘‘carers, who may or may not be family members,
are lay people in a close supportive role who share in
the illness experience of the patient and who under-
take vital care work and emotion management.’’3 We
use the term ‘‘carer’’ in this article.Accepted for publication: December 24, 2015.
0885-3924/$ - see front matter
http://dx.doi.org/10.1016/j.jpainsymman.2015.12.319
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is often willingly undertaken and can be a positive
experience but is demanding,4,5 particularly because
carers of people with long-term illness are more likely
to be older.6 Studies have mainly focused on psycho-
logical outcomes such as depression,6 and although
carers describe poor self-perceived health,7 there has
been little research on specific health outcomes such
as stroke or diabetes.
The death of a spouse may increase mortality, partic-
ularly in the first six months after bereavement8 or af-
ter an unexpected death.9 However, there are few
longitudinal studies on carers’ health when the care
recipient is still alive but entering the terminal phase.
As policies to increase the number of deaths in pa-
tients’ own homes become effective, demands on
carers will increase.10 By 2030, the worldwide annual
number of deaths is predicted to rise from 58 to 74
million. Research has focused on those caring for
someone with cancer,11e13 but diseases associated
with physical and cognitive frailty will contribute
most to this increase.14
Three ‘‘trajectories of dying’’ have been described,
cancer, organ failure (such as chronic obstructive pul-
monary disease [COPD]), and frailty (including de-
mentia).15 In each trajectory, there will be different
health, functional, and psychological problems for
which patients will require support from family and
friends.16,17 In addition, each trajectory may have a
different impact on carers; for example, longitudinal
and qualitative studies have demonstrated how the
course of COPD is lengthy and beset with considerable
uncertainty.18,19 Despite changes in the cause of
death, palliative care services still mainly care for those
with cancer11,20,21; we do not know whether different
disease trajectories and inequitable access to palliative
care and social support have a differential impact on
carer outcomes.11
At the end of life, care is often provided to the dying
person by a complex and diffuse network of both fam-
ily and friends22; however, at least half of carers pro-
vide care in the same household.1 They have poorer
quality of life and worse health than carers who do
not live with the care recipient.6 A challenge in con-
ducting research is that family members do not always
identify themselves as carers; studying cohabitees of
people dying from a progressive disease may overcome
this lack of recognition. We need to better under-
stand, in representative populations, the health
impact of caring over the latter stages of a terminal
illness and into bereavement in noncancer diseases.6Aims and Objectives
Our aim was to undertake a retrospective national
cohort study to describe the demographiccharacteristics, health outcomes, and primary care ser-
vice use of cohabitees of people dying with cancer
(lung or colorectal), dementia, or COPD during the
year before and after bereavement. Our specific objec-
tives were to 1) establish the proportion of cohabitees
identified by their general practitioner (GP, family
practitioner) as ‘‘carers’’; 2) describe demographic
and lifestyle features of adult cohabitees within two-
adult households, of people with cancer, dementia,
and COPD who are approaching the end of life; 3)
describe the prevalence and incidence of a range of
physical and psychological health outcomes and pri-
mary care service use in the cohabitee in the time pe-
riods covering one year before and after bereavement;
and 4) compare differences in health outcomes
(including mortality after bereavement) between co-
habitees of people dying with cancer, COPD, and
dementia.Methods
Data Source
In the U.K., the majority of the population is regis-
tered with a GP who provides primary care, free at the
point of use. Over 500 general practices contribute
data to The Health Improvement Network (THIN),
a primary care database containing over 12 million pa-
tients, including 3.6 million active patients (http://
www.csdmruk.imshealth.com/). Prescriptions are
entered into the system automatically, and GPs record
symptoms and diagnoses using the Read classification
system.23 THIN is broadly representative of the U.K.
population.24Ethics
The THIN scheme was approved by the National
Health Service South-East Multicenter Research Ethics
Committee in 2002. Our study received approval from
the Scientific Review Committee (August 6, 2013 refer-
ence 13-040).Population
We identified individuals cohabiting with someone
who had died with cancer, dementia, or COPD. For
each practice, we used data from when levels of com-
puter usage were considered to be acceptable, and
death recording was complete.25,26 For this analysis,
we used being a cohabitee as a ‘‘proxy’’ for being a
carer, making the assumptions that 1) the majority
of these dyads would be spouses or partners and 2) a
spouse or partner of a patient who died with cancer,
dementia, or COPD would be fulfilling a caring role
in the last year of the patient’s life and, therefore,
‘‘exposed’’ long term to the stresses that this brings.
Vol. 51 No. 5 May 2016 841Outcomes of Carers of Dying Older PeopleUsing a family number (identifier) in THIN that in-
dicates those in the same household, we identified
households where there had been a death between
2003 and 2011 in people aged 40 years or older who
had a diagnosis of cancer, dementia, or COPD, accord-
ing to Read code lists developed using published
methodology.27 To ensure that we did not select those
who had a previous diagnosis of cancer now in remis-
sion, cancer diagnoses were restricted to those re-
corded within five years before the death of the
patient. We included the two most common, none
sex-related cancers, lung and colorectal.28
Selected individuals were those in households that
contained one other adult (i.e., the cohabitee) before
the death of the patient. This was to exclude instances
where the family number represented blocks of flats
or residential homes. We also excluded households
with an age gap of greater than 15 years to remove co-
habitees living with dying adult children or parents.
The cohort of cohabitees was further restricted to
those who had been registered at the practice for at
least one year by the date of bereavement; this was
to ensure a full year of prebereavement data. Data
on individuals in the cohabitee cohort were included
from a year before bereavement until up to a year after
bereavement. Those individuals for whom informa-
tion on area-level deprivation was not available were
excluded (2%). Cohabitees aged 60 years or older at
bereavement were included in the study.Characteristics and Outcomes Under Consideration
For the cohabitee cohort, we determined the
following sociodemographic and behavioral character-
istics: age at the time of bereavement, gender, gender
of the deceased person they were cohabiting with,
area-level deprivation, excess alcohol use, and current
smoking status. Area-level deprivation was available in
the data set as quintiles of the Townsend score; the
Townsend score is linked to a patient’s postcode,
based on levels of unemployment, car ownership,
home ownership, and household overcrowding.
Excess alcohol use, in the three years before bereave-
ment, was defined as either the presence of a Read
code indicating heavy alcohol use, or a record of
weekly intake exceeding the recommended U.K. up-
per limit of 14 units in women and 21 units in men.
One U.K. unit of alcohol is equivalent to 10 mL (8
g) of ethanol. Individuals were defined as smokers if
their recorded smoking status closest to the date of
bereavement (and within three years) was as a current
smoker.
We developed a Read code list to determine
whether the cohabitees had been identified as carers
in their medical records. We used Read code lists for
hypertension, stroke, and transient ischemic attack,coronary heart disease, diabetes, and cancer to deter-
mine whether there was any record of each of these
outcomes in the primary care records of the cohabit-
ees during the year before and the year after bereave-
ment. Primary care prescription records, mapped to
British National Formulary chapters, were used to
determine whether cohabitees had been prescribed
antidepressants, hypnotics, or anxiolytics in the year
before and the year after bereavement: only newly
initiated prescriptions were considered. The number
of surgery consultations in primary care was obtained
for each cohabitee in the year before and the year af-
ter bereavement.
Individuals were followed in this analysis until they
transferred out of the practice or until the latest
date that data from the practice were available. This al-
lowed consideration of longer term mortality after
bereavement. Before and after bereavement, we
compared outcomes across the three groups of the co-
habitee cohort defined by the condition that their co-
habitee had died with: cancer, dementia, or COPD.
Statistical Analyses
We used Poisson regression for incidence rate ratios
(IRRs) for the physical and psychological morbidities
comparing the dementia and COPD groups with the
cancer group, adjusting IRRs for sex, age, area-level
deprivation, smoking status, and alcohol use. For
mortality, we calculated adjusted hazard ratios using
multivariable Cox proportional hazards modeling,
including sex, age, area-level deprivation, smoking sta-
tus, and alcohol use. Clustering by practice was
accounted for by random-effects Poisson regression.
Analyses were performed using Stata 13 (StataCorp
LP, College Station, TX).Results
Cohort Selection
We identified 79,946 individuals aged 40 years or
older, who had died with cancer (lung or colorectal),
dementia, or COPD between January 2003 and
January 2013. After excluding those who did not
have a cohabitee (the largest excluded group
61,935) and those with less than one year of follow-
up before bereavement, no Townsend score available
or an age difference with the cohabitee of more
than 15 years, we identified a cohort of 13,693
bereaved cohabitees (Fig. 1).
Cohort Characteristics
Cohabitees of those who died with dementia were
older (median age 82 years, interquartile range
[IQR] 77e86) than those who died with
cancer (median age of cohabitee 75, IQR 69e80)
Fig. 1. Selection of the cohabitee cohort.
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Over two-thirds of cohabitees were female and over
95% were in households of male/female pairs
(Table 1). Excess alcohol use was slightly higher in
cohabitees of those dying with cancer or COPDTable
Characteristics of Cohabitee Coh
Cohabitee Characteristic Cancer
Number 4248
Age median (IQR) 75 (69e80)
Women n (%) 2935 (69)
Male/female pairs n (%) 4185 (99)
Townsend deprivation quintile n (%)
1 (least deprived) 1080 (25)
2 1021 (24)
3 903 (21)
4 801 (19)
5 (most deprived) 443 (10)
Recorded excess alcohol usea 109 (2.6)
Recorded as current smokersa,b 516 (12)
Recorded carer status of cohabitee
Before bereavement: recorded
as being a carer n (%)
137 (3.2%)
After bereavement: recorded as
no longer being a carer n (%)
23 (0.5%)
COPD ¼ chronic obstructive pulmonary disease; IQR ¼ interquartile range.
aIn the three years before the death of the patient.
bSmoking data recorded for 3465 (82%) in the cancer group, 4934 (82%) in the(2.6% and 2.7%) compared to cohabitees of those
dying with dementia (1.7%). More cohabitees of
patients dying with of COPD (15%) were smokers
than cohabitees of those dying with cancer and
dementia (12% and 6.7%).1
ort at Time of Bereavement
Patient Diagnosis
COPD Dementia
6041 3404
77 (71e82) 82 (77e86)
4304 (71) 2150 (63)
5928 (98) 3230 (95)
1254 (21) 898 (26)
1334 (22) 869 (26)
1313 (22) 743 (22)
1290 (21) 561 (16)
850 (14) 333 (10)
163 (2.7) 56 (1.7)
879 (15) 227 (6.7)
290 (4.8%) 523 (15.4%)
63 (1.0%) 85 (2.5%)
COPD group, 2694 (79%) in the dementia group.
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Overall, 6.9% of cohabitees were recorded as being
carers by the GP; 15.4% of cohabitees of those with
dementia, but fewer of those who died with cancer
or COPD (3.2% and 4.8%, respectively) (Table 2).Health Before Bereavement
In the year before bereavement, we found few differ-
ences in health between cohabitees of people dying
from cancer, dementia, or COPD, as indicated by the
prevalence of primary consultations for hypertension,
stroke or transient ischemic attack, coronary heart dis-
ease, and cancer (Table 2). Similarly, there were few
differences in prescriptions of psychotropic
medications.Health After Bereavement
In the year after bereavement, consultations for the
health outcomes examined remained similar between
cohabitees of those who had died from cancer, COPD,Table
Health and Service Use Outcomes in Cohabitees of People
Bereavem
Outcome Cancer
Number 4248
Year before bereavement
Patients with consultations for
Hypertension 712 (16.8%)
Stroke or TIA 46 (1.1%)
Coronary heart disease 74 (1.7%)
Diabetes 487 (11.5%)
Cancer 141 (3.3%)
Patients with newa prescriptions for
Antidepressants 248 (6.9%)
Hypnotics 193 (4.9%)
Anxiolytics 132 (3.3%)
Number of primary care consultations
Median (IQR) 3 (1e5)
Number (%) with more than six 679 (16.0%)
Year after bereavement
Patients with consultations for
Hypertension 718 (16.9%)
Stroke or TIA 40 (0.9%)
Coronary heart disease 82 (1.9%)
Diabetes 471 (11.1%)
Cancer 162 (3.8%)
Patients with newb prescriptions for
Antidepressants 395 (11.3%)
Hypnotics 352 (9.2%)
Anxiolytics 237 (5.9%)
Number of primary care consultations
Median (IQR) 3 (1e6)
Number (%) with more than six 798 (18.8)
COPD ¼ chronic obstructive pulmonary disease; IQR ¼ interquartile range; TIA
aIncluded patients did not receive a prescription between two and one years befor
group, 5008 in the COPD group, 2773 in the dementia group. Hypnotics analysis
group. Anxiolytics analysis: 4053 in the cancer group, 5767 in the COPD group, 3
bIncluded patients did not receive a prescription in the year before bereavement. An
COPD group, 2662 in the dementia group. Hypnotics analysis: 3757 in the cance
analysis: 3921 in the cancer group, 5606 in the COPD group, 3159 in the dementor dementia. However, there was an increase in preva-
lence of prescriptions for antidepressants, hypnotics,
and anxiolytics for all groups of cohabitees.
The proportion of carers consulting on more than
six occasions rose slightly in all three groups (from
16.0% to 18.8% in cohabitees of people dying with
cancer; from 17.8% to 20.4% in cohabitees of those
dying with COPD; and from 15.5% to 17.5% in cohab-
itees of those dying with dementia) (Table 2).Incidence of Health Outcomes Before and After
Bereavement
Before and after bereavement, there were no differ-
ences in unadjusted and adjusted IRRs for consulta-
tions for hypertension, coronary heart disease,
diabetes, and cancer in cohabitees of patients with
cancer and those of people with COPD and dementia
(Fig. 2). There were no significant differences in pre-
scribing of psychotropic medications between the
three groups (Fig. 2).2
With Cancer, COPD, and Dementia, Before and After
ent
Patient Diagnosis
COPD Dementia
6041 3404
1058 (17.5%) 558 (16.4%)
71 (1.2%) 59 (1.7%)
159 (2.6%) 82 (2.4%)
717 (11.9%) 351 (10.3%)
196 (3.2%) 127 (3.7%)
324 (6.5%) 220 (7.9%)
184 (3.3%) 133 (4.4%)
161 (2.8%) 88 (2.7%)
3 (1e5) 3 (1e5)
1073 (17.8%) 528 (15.5%)
1091 (18.1%) 546 (16.0%)
70 (1.2%) 51 (1.5%)
153 (2.5%) 77 (2.3%)
687 (11.4%) 331 (9.7%)
237 (3.9%) 164 (4.8%)
617 (12.7%) 260 (9.8%)
625 (11.5%) 201 (6.7%)
384 (6.7%) 159 (5.0%)
3 (1e6) 3 (1e5)
1232 (20.4) 596 (17.5)
¼ transient ischemic attack.
e bereavement. Antidepressants analysis: 3609 included patients in the cancer
: 3950 in the cancer group, 5527 in the COPD group, 3048 in the dementia
247 in the dementia group.
tidepressants analysis: 3494 included patients in the cancer group, 4867 in the
r group, 5343 in the COPD group, 2915 in the dementia group. Anxiolytics
ia group.
Fig. 2. Results from univariable and multivariable Poisson regression models of consultations and new prescriptions in the
cohabitee cohort by patient diagnosis. Multivariable models additionally include sex, age at bereavement, Townsend depriva-
tion score quintile, excess alcohol use before bereavement, smoking status before bereavement. Clustering by practice was
accounted for by random-effects Poisson regression. TIA ¼ transient ischemic attack; CHD ¼ coronary heart disease;
COPD ¼ chronic obstructive pulmonary disease.
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dementia were less likely to receive new prescriptions
for hypnotics after bereavement (IRR 0.82, 95% CI
0.69e0.99) compared to cohabitees of people with
COPD (IRR 1.28, 95% CI 1.12e1.46) or cancer (refer-
ence group).Mortality
Follow-up was available for a median (IQR) of 3.0
(1.3e5.4) years after bereavement, during which
2222 (16.2%) died (Table 3). The largest proportion
of deaths was in cohabitees of those with dementia.
The risk of death was higher in the COPD and
Table 3
Mortality After Bereavement
Statistic
Patient Diagnosis
Cancer COPD Dementia
Number 4248 6041 3404
Number (%)
deaths
535 (12.6) 1020 (16.9) 667 (19.6)
Unadjusted
hazard ratio
1 1.35 (1.22e1.50) 1.84 (1.64e2.06)
Adjusted hazard
ratio
1 1.13 (1.02e1.26) 1.10 (0.97e1.24)
COPD ¼ chronic obstructive pulmonary disease.
Adjusted hazard ratio from a multivariable Cox proportional hazards model
including sex, age, area-level deprivation, smoking status, and alcohol use.
P-value for test of difference between groups: <0.001 in univariable model,
0.064 in multivariable model.
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hazard ratios 1.35 (95% CI 1.22e1.50) for the COPD
group and 1.84 (95% CI 1.64e2.06) for the dementia
group. However, after adjustment for confounders,
there was no significant difference in mortality risk
between the three groups.Discussion
We identified a cohort of over 13,000 bereaved co-
habitees, but few were recorded as being carers by
their GPs. There are complex reasons why carers of
those reaching the end of life may not be formally
identified. The term ‘‘carer’’ is one imposed by service
providers and may not be accepted or felt relevant by
the carers themselves. They may not need help when
they are asked and only seek assistance at a time of
crisis. They may feel guilty or ambivalent about ‘‘not
coping,’’ or have difficulty in acknowledging how
serious the illness is.29,30
A higher proportion of cohabitees of people with
dementia were recognized as carers. This may have
been driven by policy, in particular the English Na-
tional Dementia Strategy,31 which promotes the recog-
nition of dementia in primary care. After this, GPs
were incentivized to create a register of patients diag-
nosed with dementia and address their needs.
We found little difference between the three groups
of cohabitees in health or psychological outcomes in
the year before or after bereavement. After bereave-
ment, there was an increase in prescriptions for anti-
depressants, hypnotics, and anxiolytics. There was an
increase in primary care consultations in the year after
bereavement but no difference in longer term mortal-
ity risk between the three groups. Most previous work
on caring at the end of life has been in cancer where it
is often stated that there is a more predictable disease
trajectory and access to services is better.10,20,21 It has
been suggested that carers of people with a moreunpredictable disease trajectory (such as dementia
or COPD) may have poorer access to palliative care
support10 and experience higher stress and worse
health. This is particularly emphasized in dementia
where carers manage behavioral disturbance.32 How-
ever, we found that all three groups of cohabitees
had similar health outcomes.
There are a number of possible explanations for our
findings. Although it is assumed it is more stressful car-
ing for a person with dementia, the burden of caring
for someone with cancer or COPD may be as great,
but different in nature. A person dying with COPD
may have significant physical nursing needs at
home.21 Our results also may be explained by the
‘‘healthy caregiver effect’’: healthier older people are
selected into a caregiving role.33 Carers who could
not cope may have already moved the care recipient
to a care home. In addition, those cohabitees who
were in poor health may have died before their care
recipient and these were excluded. Thus the carers
in our cohort may have had similar levels of overall
‘‘resilience’’ leading to fewer differences in health out-
comes between the groups. Caring is a highly individ-
ual experience, and studies of carers of people with
dementia and cancer suggest that it is not specific
symptom, but carers’ appraisal of the situation that
determines how they cope.34,35 It also may be that
more systemic factors, such as the availability of sup-
port, influence health after bereavement rather than
the cause of bereavement itself.6
The proportion of cohabitees having more than six
consultations per year rose slightly in all three groups
after bereavement. This has been found in previous
studies,13 and the effect is maintained up to five years
after the loss.36 We identified spouse pairs who are, by
selection for this study, attending the same general
practice; staff are likely to be aware of the bereave-
ment and may have offered increased support.37 It
has been suggested that carers of those dying from
cancer receive better care because they are supported
by hospices.38 Our findings suggest that cohabitees of
those dying from cancer, COPD, and dementia
received similar levels of primary care support.
Bereavement is emotionally stressful and a signifi-
cant proportion of carers develop complicated grief,
depression, or anxiety.39 We found an increase in
prescriptions for antidepressants, hypnotics, and anxi-
olytics, in keeping with findings that one in five older
people will receive a new psychotropic drug prescrip-
tion in the year after bereavement.40 We did find,
however, that carers of people who died with dementia
had a lower rate of new prescriptions for hypnotics. It
may be that their sleep improved after bereavement as
they no longer had to manage the nocturnal distur-
bance that occurs in dementia, or this may be artifact
846 Vol. 51 No. 5 May 2016Sampson et al.as cohabitees of people with dementia may have
already been prescribed hypnotics before bereave-
ment and, therefore, in receipt of fewer new prescrip-
tions after bereavement.
We found no significant difference in mortality be-
tween our three groups of cohabitees. In unadjusted
analysis, mortality risk was significantly increased in co-
habitees of those with dementia (hazard ratio 1.84,
95% CI 1.64e2.06); however, controlled analysis sug-
gested that older age mainly influenced this. Despite
consistent findings that caregivers have poorer health,
the literature on caregiver mortality is contradictory.
Two large studies41,42 found that spouses experienced
significantly increased risk of mortality. However,
others demonstrate reduced mortality risk in care-
givers.13,33,43,44 This may, in part, be a result of the
‘‘healthy caregiver effect,’’ or the fact that long-term
chronic disease of any type gives caregivers the oppor-
tunity to adapt, reflect, and act on their own health. In
addition, sudden unexpected bereavement has a
greater relative mortality impact than bereavement
preceded by chronic disease.9Strengths and Limitations
Using a large general practice database that repre-
sents routine clinical practice in U.K., primary care
avoids the recruitment challenges, selection, and
recall bias inherent in many longitudinal cohort
studies of carers. In particular, those carers who are
most stressed by their role are less likely to participate
in research.45 Our methodology overcomes this issue.
We assumed that cohabitees are fulfilling a caring role;
we have used being a cohabitee as a ‘‘proxy’’ for being
a carer and thus assumed that they are exposed to the
stresses this brings. We cannot be sure that all cohab-
iting pairs were spouses. However, the contrasting sex
of the pairs (99% male/female pairs for cancer cohab-
itees and 98% for COPD cohabitees) suggests that this
is the case. This limitation would occur in all three of
the groups of cohabitees that we compared, but,
slightly fewer of the dementia cohabitees were in
male/female pairs (95%). This may reflect the older
age of this cohort and that some of these cohabitees
may have been siblings who had moved in together
because of prior spouse bereavement, increasing de-
pendency or following the diagnosis of dementia.
Dementia is underrecognized in primary care in the
U.K.46,47 Thus, it may be that our cohort was more
likely to contain those whose dementia was recognized
because of problematic symptoms or carer stress. For
COPD, there is evidence that observed prevalence in
the THIN database is similar to national data.48 The
recording of death in the THIN database has been
validated.49 We identified people who died with a
particular diagnosis and studied outcomes in theircohabitees, but we cannot be sure that cancer,
COPD, or dementia was the actual cause of death.
There may have been residual confounding, and we
may not have adjusted for all variables influencing
our outcomes. We selected a limited number of health
outcomes based on the commonest causes of death
and comorbidity in the U.K.50 Future studies could
examine a wider range of carer health outcomes.
Implications
In general practice, we may underestimate the num-
ber of family and other close persons caring for a
dying person. Day-to-day, GPs may acknowledge this
and support carers, but, if not coded, this work is
not acknowledged by services and policy makers. Iden-
tifying carers is a key step toward providing appro-
priate health care, for example, supportive
interventions may improve carers’ psychological
distress.12
Our finding that cohabitee health was similar both
before and after bereavement, whether the cared-for
person died of cancer, COPD, or dementia, suggests
that these diseases, with differing trajectories of
decline, produce similar effects on carers. Complex in-
terventions that involve proactively seeking carers in
primary care are in development,30 but these may
need to be implemented via top-down policy
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